Search research articles
Contact Us
Filters
Showing results (81-90 of 349) with videos related to
Page
of 35
Sort By:
Expert Opinion on Drug Safety
|
June 9, 2016
An analysis of QTc prolongation with atypical antipsychotic medications and selective serotonin reuptake inhibitors using a large ECG record database
Sang-In Park, Hyungmi An, Anhye Kim, et al.
Plos One
|
January 18, 2018
A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study
Hyewon Chung, Jaeseong Oh, Seo Hyun Yoon, et al.
Clinical Pharmacology in Drug Development
|
March 10, 2026
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Fenofibrate 20/145 mg and the Corresponding Individual Components
Seungri Lee, Juyoung Khwarg, Sungyeun Bae, et al.
Investigative Radiology
|
July 26, 2023
Safety, Tolerability, and Pharmacokinetics of a Novel Macrocyclic Gadolinium-Based Contrast Agent, HNP-2006, in Healthy Subjects
Ki Young Huh, Woo Kyung Chung, Heejeong Lee, et al.
Clinical Therapeutics
|
March 1, 2011
Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjects
Seunghwan Lee, Seo Hyun Yoon, Joo-Youn Cho, et al.
Analytical Biochemistry
|
September 14, 2020
Optimization and validation of a fluorogenic dipeptidyl peptidase 4 enzymatic assay in human plasma
Hyunyee Yoon, Su Hee Cho, Yu Rim Seo, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 24, 2022
A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808
Tae Kyu Chung, Hyun A Lee, Kyeong-Ryoon Lee, et al.
Drug Design, Development and Therapy
|
December 13, 2024
Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation
Woo Kyung Chung, Inseung Jeon, In-Jin Jang, et al.
Rheumatology (Oxford, England)
|
May 7, 2019
URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers
Hyun A Lee, Kyung-Sang Yu, Sang-In Park, et al.
Translational and Clinical Pharmacology
|
April 11, 2020
Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects
Xuanyou Jin, Eunwoo Kim, Ki Young Huh, et al.
Page
of 35
Search research articles
Search
Showing results (81-90 of 349) with videos related to
Sort By:
Page
of 35
Expert Opinion on Drug Safety
|
June 9, 2016
An analysis of QTc prolongation with atypical antipsychotic medications and selective serotonin reuptake inhibitors using a large ECG record database
Sang-In Park, Hyungmi An, Anhye Kim, et al.
Plos One
|
January 18, 2018
A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study
Hyewon Chung, Jaeseong Oh, Seo Hyun Yoon, et al.
Clinical Pharmacology in Drug Development
|
March 10, 2026
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Fenofibrate 20/145 mg and the Corresponding Individual Components
Seungri Lee, Juyoung Khwarg, Sungyeun Bae, et al.
Investigative Radiology
|
July 26, 2023
Safety, Tolerability, and Pharmacokinetics of a Novel Macrocyclic Gadolinium-Based Contrast Agent, HNP-2006, in Healthy Subjects
Ki Young Huh, Woo Kyung Chung, Heejeong Lee, et al.
Clinical Therapeutics
|
March 1, 2011
Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjects
Seunghwan Lee, Seo Hyun Yoon, Joo-Youn Cho, et al.
Analytical Biochemistry
|
September 14, 2020
Optimization and validation of a fluorogenic dipeptidyl peptidase 4 enzymatic assay in human plasma
Hyunyee Yoon, Su Hee Cho, Yu Rim Seo, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 24, 2022
A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808
Tae Kyu Chung, Hyun A Lee, Kyeong-Ryoon Lee, et al.
Drug Design, Development and Therapy
|
December 13, 2024
Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation
Woo Kyung Chung, Inseung Jeon, In-Jin Jang, et al.
Rheumatology (Oxford, England)
|
May 7, 2019
URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers
Hyun A Lee, Kyung-Sang Yu, Sang-In Park, et al.
Translational and Clinical Pharmacology
|
April 11, 2020
Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects
Xuanyou Jin, Eunwoo Kim, Ki Young Huh, et al.
Page
of 35